-
GTA 6 Release Date Confirmed for November 19; Troubleshooting Pre-load and Launch Errors
-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Dolphin Congratulates Shore Fire Media and Its Clients on 20 GRAMMY(R) Nominations, Including 10 Best Album Nods Across Diverse Genres
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Dermata Announces U.S. Trademark Registration for TOME(R)
-
Olenox October Bitcoin Production Climbs to Three-Month High as Uptime and Hashrate Advance
-
5E Advanced Materials Highlights Commercial Momentum in First Month as an Operating Borates Producer
-
Trout CPA Expands Partner Leadership with Michael Carr and Dan Lerew
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
Jumia Reports Third Quarter 2026 Results
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
What to Do When Two Households Become One
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
TrizCom PR Wins Fourth PRSA Dallas Best of Show Award; Founder Jo Trizila Receives Norm Teich Award
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
No longer a death sentence: Four decades of living with HIV
Forty years after the discovery of HIV, AFP looks at how far we have come in fighting a deadly virus that was once shrouded in fear and shame but is now treated as a manageable chronic condition.
- 1981: First alert -
In June 1981, US epidemiologists report five cases of a rare form of pneumonia in gay men in California.
It is the first alert about Acquired Immune Deficiency Syndrome (AIDS), still unknown and unnamed.
Doctors then identify "opportunistic infections" among intravenous drug users and in haemophiliacs and Haitian residents in the United States.
The term AIDS appears for the first time in 1982. The disease is wrongly presented as a "homosexual disorder".
- 1983: Identifying HIV -
In January 1983, researchers in France, Francoise Barre-Sinoussi and Jean-Claude Chermann, working under Luc Montagnier, identify the virus that "might be" responsible for AIDS.
Their discovery is published on May 20 in the journal Science.
The following year, US specialist Robert Gallo is said to have found the "probable" cause of AIDS, the retrovirus HTLV-III.
The two viruses turn out to be the same, and in May 1986 it becomes officially known as the Human Immunodeficiency Virus, or HIV.
- 1987: Anti-retroviral treatment -
In March 1987, the first anti-retroviral treatment known as AZT is authorised in the US. It is expensive and has severe side effects.
The United States and France agree that Gallo and Montagnier should get joint credit for discovering HIV. But the 2008 Nobel prize goes to Barre-Sinoussi and Montagnier.
- Early 1990s: Fallen stars -
In July 1985, US actor Rock Hudson announces he has AIDS. His death three months later is the first high-profile AIDS death.
A host of other stars succumb to the disease, including legendary pianist Liberace (February 1987), British singer and Queen frontman Freddie Mercury (November 1991), and the Russian dancer and choreographer Rudolf Nureyev (January 1993).
In 1994, AIDS becomes the leading cause of death among Americans aged between 25 and 44.
- 1995-96: New approach -
Two new classes of drugs signal the start of combinations of different anti-retroviral therapies.
Called tri-therapies, they provide the first effective treatment for HIV.
1996 is the first year in which the number of AIDS deaths declines in the United States. While US numbers decline, they rocket in Africa, where AIDS is the biggest killer by 1999.
- 2001: Generic medicine -
In 2000, UNAIDS and five major drug companies sign a deal to distribute affordable treatments in poorer countries.
A year later, the World Trade Organization changes intellectual property rules to allow developing countries to make generic versions of patent-protected HIV treatments.
In 2004, the country with the world's highest HIV caseload, South Africa, ends years of AIDS denialism and makes anti-retroviral treatments available through the public health system.
- 2010: First cure -
Timothy Ray Brown, an American man who had been living with HIV for over a decade, is cured of the virus after undergoing cancer treatment.
Brown underwent two bone marrow transplants containing a mutation of a gene that blocks HIV from attacking host cells.
- 2012: Preventive pill -
In July 2012, the first-ever daily pill to help prevent HIV infection is approved by US regulators. Truvada is a pre-exposure prophylaxis, or PrEP, taken by high-risk people who are HIV-negative in order to prevent them from being infected.
- 2017: Treatment spreads -
For the first time, more than half of all people living with HIV are receiving anti-retroviral treatment.
The proportion rises to three-quarters: 28.7 million people are being treated out of 38.4 million who are infected, according to UNAIDS in 2021.
- 2020-2021: Covid setback -
The Covid-19 pandemic disrupts access to health systems, testing and treatment, slowing progress in the fight against AIDS, which in 40 years has killed 40.1 million people.
In 2021, 650,000 AIDS deaths and 1.5 million new infections are recorded.
UNAIDS hopes to end AIDS as a public health threat by 2030.
M.O.Allen--AT